Question 1

What is Endospan?

Accepted Answer

Endospan is a Entity.

Question 2

How often does Endospan appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Endospan first tracked by Ergen?

Accepted Answer

First tracked on May 18, 2026.

Question 4

When was Endospan last mentioned in news?

Accepted Answer

Last active on May 18, 2026.

Question 5

What is Endospan's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Endospan in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Endospan?

Accepted Answer

Artivion acquires Endospan after FDA approval (May 18, 2026, 6 articles).

Question 8

How did the "Artivion acquires Endospan after FDA approval" event impact Endospan?

Accepted Answer

Endospan>>> was acquired by Artivion>>> for $135 million upfront, with potential for up to $200 million in additional consideration. This acquisition integrates Endospan>>>'s Nexus Aortic Arch System into Artivion>>>'s comprehensive portfolio, facilitating broader access to its innovative technology.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.